Pasithea Therapeutics Operating Expenses Growth & History (KTTA)

Pasithea Therapeutics's operating expenses was $20.9M for fiscal 2025.

View full Pasithea Therapeutics company overview

Pasithea Therapeutics annual operating expenses history

Pasithea Therapeutics annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$20.9M$6.6M+46.37%
20242024-12-31$14.2M−$1.7M−10.82%
20232023-12-31$16.0M$3.0M+23.28%
20222022-12-31$13.0M$8.5M+187.72%
20212021-12-31$4.5M

Pasithea Therapeutics operating expenses trends

Between the periods ended 2021-12-31 and 2025-12-31, Pasithea Therapeutics's operating expenses increased from $4.5M to $20.9M, a change of $16.4M. The latest reported quarter, Q2 2026, shows $5.7M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Pasithea Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about KTTA yet. Start the conversation.

Write the first post